Induction of HOXA9 expression in three-dimensional organotypic culture of the Claudin-low breast cancer cells

Por Li, Miao, Li, Xi, Zhuang, Yan, Wang, Yan, Burow, Matthew E., Collins-Burow, Bridgette, Xue, Min, Song, Chengjie, Shan, Bin
Publicado no Oncotarget (2016)

Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line

Por Martin, Elizabeth C., Bratton, Melyssa R., Zhu, Yun, Rhodes, Lyndsay V., Tilghman, Syreeta L., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado em 2012

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

Por Tate, Chandra R, Rhodes, Lyndsay V, Segar, H Chris, Driver, Jennifer L, Pounder, F Nell, Burow, Matthew E, Collins-Burow, Bridgette M
Publicado em 2012

miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling

Por Martin, Elizabeth C., Krebs, Adrienne E., Burks, Hope E., Elliott, Steven, Baddoo, Melody, Collins-Burow, Bridgette M., Flemington, Erik K., Burow, Matthew E.
Publicado em 2014

Laser Direct-Write onto Live Tissues: A Novel Model for Studying Cancer Cell Migration

Por Burks, Hope E., Phamduy, Theresa B., Azimi, Mohammad S., Saksena, Jayant, Burow, Matthew E., Collins-Burow, Bridgette M., Chrisey, Douglas B., Murfee, Walter L.
Publicado no J Cell Physiol (2016)

microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity

Por Martin, Elizabeth C, Rhodes, Lyndsay V, Elliott, Steven, Krebs, Adrienne E, Nephew, Kenneth P, Flemington, Erik K, Collins-Burow, Bridgette M, Burow, Matthew E
Publicado em 2014

Glyceollin-elicited soy protein consumption induces distinct transcriptional effects compared to standard soy protein()

Por Wood, Charles E., Boue, Stephen M., Collins-Burow, Bridgette M., Rhodes, Lyndsay V., Register, Thomas C., Cline, J. Mark, Dewi, Fitriya N., Burow, Matthew E.
Publicado em 2011

Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration

Por Zhou, Changhua, Zhong, Qiu, Rhodes, Lyndsay V, Townley, Ian, Bratton, Melyssa R, Zhang, Qiang, Martin, Elizabeth C, Elliott, Steven, Collins-Burow, Bridgette M, Burow, Matthew E, Wang, Guangdi
Publicado em 2012

Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer

Por Bratton, Melyssa R., Martin, Elizabeth C., Elliott, Steven, Rhodes, Lyndsay V, Collins-Burow, Bridgette M., McLachlan, John A., Wiese, Thomas E., Boue, Stephen M., Burow, Matthew E.
Publicado no J Steroid Biochem Mol Biol (2015)

Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer

Por Rhodes, Lyndsay V., Martin, Elizabeth C., Segar, H. Chris, Miller, David F. B., Buechlein, Aaron, Rusch, Douglas B., Nephew, Kenneth P., Burow, Matthew E., Collins-Burow, Bridgette M.
Publicado no Oncotarget (2015)

Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative breast cancers to tamoxifen through ERα Re-expression

Por Anbalagan, Muralidharan, Sheng, Mei, Fleischer, Brian, Zhang, Yifang, Gao, Yuanjun, Hoang, Van, Matossian, Margarite, Burks, Hope E, Burow, Matthew E, Collins-Burow, Bridgette M., Hangauer, David, Rowan, Brian G
Publicado no Mol Cancer Res (2017)

Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model

Por Matossian, Margarite D., Burks, Hope E., Elliott, Steven, Hoang, Van T., Bowles, Annie C., Sabol, Rachel A., Bunnell, Bruce A., Martin, Elizabeth C., Burow, Matthew E., Collins-Burow, Bridgette M.
Publicado no Oncoscience (2018)

Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer

Por RHODES, LYNDSAY V., TILGHMAN, SYREETA L., BOUE, STEPHEN M., WANG, SHUCHUN, KHALILI, HAFEZ, MUIR, SHANNON E., BRATTON, MELYSSA R., ZHANG, QIANG, WANG, GUANGDI, BUROW, MATTHEW E., COLLINS-BUROW, BRIDGETTE M.
Publicado em 2012

Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition

Por ANTOON, JAMES W., NITZCHKE, ASHLEY M., MARTIN, ELIZABETH C., RHODES, LYNDSAY V., NAM, SEUNGYOON, WADSWORTH, SCOTT, SALVO, VIRGILO A., ELLIOTT, STEVEN, COLLINS-BUROW, BRIDGETTE, NEPHEW, KENNETH P., BUROW, MATTHEW E.
Publicado em 2013

Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes

Por Matossian, Margarite D., Elliott, Steven, Hoang, Van T., Burks, Hope E., Phamduy, Theresa B., Chrisey, Douglas B., Zuercher, William J., Drewry, David H., Wells, Carrow, Collins-Burow, Bridgette, Burow, Matthew E.
Publicado no PLoS One (2017)

MicroRNA-335-5p and -3p Synergize to Inhibit Estrogen Receptor Alpha Expression and Promote Tamoxifen Resistance

Por Martin, Elizabeth C., Conger, Adrienne K., Yan, Thomas J., Hoang, Van T., Miller, David F. B., Buechlein, Aaron, Rusch, Douglas B., Nephew, Kenneth P., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado no FEBS Lett (2017)

Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells

Por Rhodes, Lyndsay V., Bratton, Melyssa R., Zhu, Yun, Tilghman, Syreeta L., Muir, Shannon E., Salvo, Virgilio A., Tate, Chandra R., Elliott, Steven, Nephew, Kenneth P., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado em 2011

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

Por RHODES, LYNDSAY V., NITSCHKE, ASHLEY M., SEGAR, H. CHRIS, MARTIN, ELIZABETH C., DRIVER, JENNIFER L., ELLIOTT, STEVEN, NAM, SEUNG YOON, LI, MENG, NEPHEW, KENNETH P., BUROW, MATTHEW E., COLLINS-BUROW, BRIDGETTE M.
Publicado em 2011

Antiestrogenic Activity of Flavonoid Phytochemicals Mediated via the c-Jun N-terminal Protein Kinase Pathway: Cell-type specific regulation of estrogen receptor alpha

Por Collins-Burow, Bridgette M., Antoon, James W., Frigo, Daniel E., Elliott, Steven, Weldon, Christopher B., Boue, Stephen M., Beckman, Barbara S., Curiel, Tyler J., Alam, Jawed, McLachlan, John A., Burow, Matthew E.
Publicado em 2012

Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation

Por Conger, Adrienne K., Martin, Elizabeth C., Yan, Thomas J., Rhodes, Lyndsay V., Hoang, Van T., La, Jacqueline, Anbalagan, Muralidharan, Burks, Hope E., Rowan, Brian G., Nephew, Kenneth P., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado no Noncoding RNA (2016)